📈 Medical cannabis exploration + SEC reporting initiatives + strategic business development. $CBDL is outlining multiple areas of focus for its next phase of corporate growth.
#CBDL#StockNews#PennyStocks
https://t.co/TD2Hjgchno @TenAssocLLC
Lebanese cannabis oil triggered cell death in lung and breast cancer cells!
The cannabis oil extract appears to fight these cancer cells mainly by triggering apoptosis (the body’s controlled process of programmed cell death) through the cell’s internal death pathway.
It also changed proteins involved in the cell’s normal recycling and cleanup process, boosted a key signaling protein that can push cells toward death, and filled the cancer cells with many large bubble-like structures — a pattern that resembles a rare type of cell death called methuosis.
https://t.co/18zziKGlTN
Goodmorning $CBDL we have some big announcements today!
We’re expanding into the medical marijuana market. Will be a huge revenue driver.
Along with this we are working on becoming fully SEC reporting!
https://t.co/3P2Hhjzc9D
States that legalized recreational cannabis saw people using it for sleep more often — but not alcohol or sleeping pills.
After legalization, people used cannabis for sleep more often (even after controlling for demographics, sleep quality, mental/physical health, and prior use).
No increase in using alcohol or sleep medications for sleep.
No increase in combining cannabis with other sleep aids.
https://t.co/xWrSrWodGd
New modified CBD compound kills hard-to-treat breast cancer cells!
TNBC is an aggressive breast cancer that resists standard hormone and targeted therapies.
Researchers modified CBD into a new compound, MCPB-21, which strongly kills TNBC cells.
It works by raising harmful reactive oxygen species (ROS) that trigger cell death.
MCPB-21 shows promise as a TNBC treatment by driving ROS-related cell death while also inducing protective autophagy.
https://t.co/xcNA7K1cw4
Medical cannabis works at surprisingly low blood levels!
15–30 ng/mL THC was associated with pain relief in diabetic nerve pain.
Levels under 20 ng/mL were linked to reduced eye pressure.
About 7.5–10 ng/mL improved tic symptoms.
For nabiximols: 1–10 ng/mL THC was identified as a preliminary range for nerve pain and muscle spasticity in multiple sclerosis.
For chemotherapy-related nausea:
Nabilone: roughly 1–5 ng/mL.
Dronabinol: roughly 5–15 ng/mL THC.
https://t.co/LPpLLGdmVL
CBD is showing REAL power against deadly glioblastoma (brain cancer)!
CBD seems to fight brain tumors in several ways:
It messes with the signals that tell cancer cells to grow.
It slows down or stops the tumor cells from multiplying.
It can make regular chemotherapy drugs work better on the cancer.
https://t.co/1mUbyq8Hhp
CBDA + CBD suppository cuts menstrual cramps by 44–68% !
Overall, average pain score dropped from 6.38 to 3.54 — a 44% reduction in pain.
Women who started with milder pain saw an even bigger improvement: from 5.43 down to 1.71 — a 68% reduction.
81% of the women ended up needing fewer oral painkillers.
https://t.co/IxO19YNHQ5
✅ Dec 2025: nearly $4M of convertible debt converted to equity.
✅ March 2026: acquired Frame’s technology.
✅ Sept 2026: V1 testnet goes live.
✅ Nov 2026: four chains connected on the V3 testnet.
The path to TGE is taking shape and becoming clearer.
$CRCW #Frame
THC & CBD) show strong anti-tumor effects in pancreatic cancer!
They can trigger cancer cells to die (apoptosis)
They can stop cancer cells from multiplying (cell cycle arrest)
They can reduce the growth of new blood vessels that feed the tumor (anti-angiogenesis)
They can help adjust the body’s immune response around the tumor
They can lower harmful oxidative stress in cells.
https://t.co/4g1mbbrkeY